Main > ONCOLOGY (**) > Breast Cancer *** > Treatment * > Co: JP. E. Eribulin Mesylate ***

---

Co: JP. E. Eribulin Mesylate ***'s subsections
Approved In: AU; CA; EU; JP & USA
Company
Halichondrin B Synthetic Analog
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 18
Patent>UpDate: 2016. 07.26.
TradeMark
TradeMark Web-Site
UpDate: 2012. 09.07.

Co: JP. E. Eribulin Mesylate ***'s products
This section has no products